429 related articles for article (PubMed ID: 32998766)
1. Ferritin measurement IN Donors-Effectiveness of iron Monitoring to diminish iron deficiency and low haemoglobin in whole blood donors (FIND'EM): study protocol for a stepped wedge cluster randomised trial.
Sweegers MG; Zalpuri S; Quee FA; Huis In 't Veld EMJ; Prinsze FJ; Hoogendijk EO; Twisk JWR; van Weert AWM; de Kort WLAM; van den Hurk K
Trials; 2020 Oct; 21(1):823. PubMed ID: 32998766
[TBL] [Abstract][Full Text] [Related]
2. Effectiveness of ferritin-guided donation intervals in whole-blood donors in the Netherlands (FIND'EM): a stepped-wedge cluster-randomised trial.
Meulenbeld A; Ramondt S; Sweegers MG; Quee FA; Prinsze FJ; Hoogendijk EO; Swinkels DW; van den Hurk K
Lancet; 2024 Jun; ():. PubMed ID: 38880108
[TBL] [Abstract][Full Text] [Related]
3. Longer-term efficiency and safety of increasing the frequency of whole blood donation (INTERVAL): extension study of a randomised trial of 20 757 blood donors.
Kaptoge S; Di Angelantonio E; Moore C; Walker M; Armitage J; Ouwehand WH; Roberts DJ; Danesh J; Thompson SG;
Lancet Haematol; 2019 Oct; 6(10):e510-e520. PubMed ID: 31383583
[TBL] [Abstract][Full Text] [Related]
4. Whole blood donor behavior and availability after deferral: Consequences of a new ferritin monitoring policy.
Spekman MLC; Ramondt S; Sweegers MG
Transfusion; 2021 Apr; 61(4):1112-1121. PubMed ID: 33368385
[TBL] [Abstract][Full Text] [Related]
5. Ferritin-guided iron supplementation in whole blood donors: optimal dosage, donor response, return and efficacy (FORTE)-a randomised controlled trial protocol.
Karregat J; Sweegers MG; Quee FA; Weekamp HH; Swinkels DW; Novotny VMJ; Zaaijer HL; van den Hurk K
BMJ Open; 2022 Mar; 12(3):e056316. PubMed ID: 35264362
[TBL] [Abstract][Full Text] [Related]
6. Oral or parenteral iron supplementation to reduce deferral, iron deficiency and/or anaemia in blood donors.
Smith GA; Fisher SA; Doree C; Di Angelantonio E; Roberts DJ
Cochrane Database Syst Rev; 2014 Jul; 2014(7):CD009532. PubMed ID: 24990381
[TBL] [Abstract][Full Text] [Related]
7. Efficiency and safety of varying the frequency of whole blood donation (INTERVAL): a randomised trial of 45 000 donors.
Di Angelantonio E; Thompson SG; Kaptoge S; Moore C; Walker M; Armitage J; Ouwehand WH; Roberts DJ; Danesh J;
Lancet; 2017 Nov; 390(10110):2360-2371. PubMed ID: 28941948
[TBL] [Abstract][Full Text] [Related]
8. First results of a ferritin-based blood donor deferral policy in the Netherlands.
Vinkenoog M; van den Hurk K; van Kraaij M; van Leeuwen M; Janssen MP
Transfusion; 2020 Aug; 60(8):1785-1792. PubMed ID: 32533600
[TBL] [Abstract][Full Text] [Related]
9. Prevalence of blood donor iron deficiency and feasibility ferritin-based iron replacement: a blood collection agency-based study.
Gorlin J; Katz L; Elsmore D; Kirbach K; Erickson Y; Hove A; Black C; Walsh-Jahnke R
Vox Sang; 2016 Aug; 111(2):206-8. PubMed ID: 27172604
[TBL] [Abstract][Full Text] [Related]
10. Genetic determinants of ferritin, haemoglobin levels and haemoglobin trajectories: results from Donor InSight.
Timmer T; Tanck M; Penkett C; Stirrups K; Gleadall N; de Kort W; van der Schoot E; van den Hurk K
Vox Sang; 2021 Aug; 116(7):755-765. PubMed ID: 33491795
[TBL] [Abstract][Full Text] [Related]
11. Donation-induced iron depletion is significantly associated with low hemoglobin at subsequent donations.
Prinsze FJ; de Groot R; Timmer TC; Zalpuri S; van den Hurk K
Transfusion; 2021 Dec; 61(12):3344-3352. PubMed ID: 34596892
[TBL] [Abstract][Full Text] [Related]
12. A computational model for prediction of ferritin and haemoglobin levels in blood donors.
Paalvast Y; Moazzen S; Sweegers M; Hogema B; Janssen M; van den Hurk K
Br J Haematol; 2022 Oct; 199(1):143-152. PubMed ID: 35855538
[TBL] [Abstract][Full Text] [Related]
13. The importance of plasma ferritin values in blood donors for the evaluation of body iron store in a five-month period.
Ćatović-Baralija E; Ahmetović-Karić G; Hasić S; Avdagić N; Babić N
Med Glas (Zenica); 2021 Feb; 18(1):7-11. PubMed ID: 33155462
[TBL] [Abstract][Full Text] [Related]
14. Low hemoglobin deferral in blood donors.
Mast AE
Transfus Med Rev; 2014 Jan; 28(1):18-22. PubMed ID: 24332843
[TBL] [Abstract][Full Text] [Related]
15. Iron deficiency among blood donors: experience from the Danish Blood Donor Study and from the Copenhagen ferritin monitoring scheme.
Rigas AS; Pedersen OB; Magnussen K; Erikstrup C; Ullum H
Transfus Med; 2019 Apr; 29 Suppl 1():23-27. PubMed ID: 29024114
[TBL] [Abstract][Full Text] [Related]
16. The INTERVAL trial to determine whether intervals between blood donations can be safely and acceptably decreased to optimise blood supply: study protocol for a randomised controlled trial.
Moore C; Sambrook J; Walker M; Tolkien Z; Kaptoge S; Allen D; Mehenny S; Mant J; Di Angelantonio E; Thompson SG; Ouwehand W; Roberts DJ; Danesh J
Trials; 2014 Sep; 15():363. PubMed ID: 25230735
[TBL] [Abstract][Full Text] [Related]
17. The impact of iron supplementation efficiency in female blood donors with a decreased ferritin level and no anaemia. Rationale and design of a randomised controlled trial: a study protocol.
Pedrazzini B; Waldvogel S; Cornuz J; Vaucher P; Bize R; Tissot JD; Pecoud A; Favrat B
Trials; 2009 Jan; 10():4. PubMed ID: 19149890
[TBL] [Abstract][Full Text] [Related]
18. [Prevention of anemia in blood donors].
Fillet AM; Gross S
Transfus Clin Biol; 2017 Sep; 24(3):143-147. PubMed ID: 28687193
[TBL] [Abstract][Full Text] [Related]
19. High-dose intravenously administered iron versus orally administered iron in blood donors with iron deficiency: study protocol for a randomised, controlled trial.
Macher S; Drexler C; Lindenau I; Sareban N; Schlenke P; Amrein K
Trials; 2016 Oct; 17(1):527. PubMed ID: 27793204
[TBL] [Abstract][Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]